GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Cyclically Adjusted Book per Share

Pharma Mar (XMAD:PHM) Cyclically Adjusted Book per Share : €5.95 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharma Mar's adjusted book value per share for the three months ended in Mar. 2024 was €11.005. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.95 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pharma Mar's average Cyclically Adjusted Book Growth Rate was 18.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 26.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharma Mar was 26.10% per year. The lowest was -10.30% per year. And the median was 9.50% per year.

As of today (2024-05-22), Pharma Mar's current stock price is €36.02. Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €5.95. Pharma Mar's Cyclically Adjusted PB Ratio of today is 6.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 12.06.


Pharma Mar Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pharma Mar's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Cyclically Adjusted Book per Share Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.56 2.85 3.66 4.77 5.72

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.03 5.29 5.54 5.72 5.95

Competitive Comparison of Pharma Mar's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted PB Ratio falls into.



Pharma Mar Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.005/122.7621*122.7621
=11.005

Current CPI (Mar. 2024) = 122.7621.

Pharma Mar Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.756 101.081 4.562
201409 3.792 100.441 4.635
201412 3.497 100.251 4.282
201503 3.829 99.474 4.725
201506 4.179 101.138 5.073
201509 4.420 99.559 5.450
201512 4.168 100.268 5.103
201603 3.758 98.638 4.677
201606 3.388 100.333 4.145
201609 3.252 99.737 4.003
201612 2.843 101.842 3.427
201703 2.713 100.896 3.301
201706 2.558 101.848 3.083
201709 2.126 101.524 2.571
201712 1.457 102.975 1.737
201803 1.385 102.122 1.665
201806 1.628 104.165 1.919
201809 1.743 103.818 2.061
201812 1.159 104.193 1.366
201903 0.618 103.488 0.733
201906 0.007 104.612 0.008
201909 -0.287 103.905 -0.339
201912 0.615 105.015 0.719
202003 4.398 103.469 5.218
202006 5.848 104.254 6.886
202009 5.406 103.521 6.411
202012 5.671 104.456 6.665
202103 7.025 104.857 8.225
202106 7.430 107.102 8.516
202109 7.951 107.669 9.066
202112 9.879 111.298 10.897
202203 11.205 115.153 11.945
202206 11.438 118.044 11.895
202209 11.736 117.221 12.291
202212 12.313 117.650 12.848
202303 12.071 118.948 12.458
202306 11.698 120.278 11.940
202309 11.588 121.343 11.724
202312 10.966 121.300 11.098
202403 11.005 122.762 11.005

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pharma Mar  (XMAD:PHM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharma Mar's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=36.02/5.95
=6.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 12.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharma Mar Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Industry
Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines